BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 447475)

  • 1. Topical induction of delayed hypersensitivity in the bladder.
    Burke C; Kumar V; Olsson CA
    Invest Urol; 1979 May; 16(6):421-7. PubMed ID: 447475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results obtained by intravesical instillation of BCG in superficial bladder tumors].
    Romics I; Dietmar B; Christoph R
    Orv Hetil; 1990 Jan; 131(1):25-8. PubMed ID: 2405331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of DNFB skin testing in patients with bladder cancer (author's transl)].
    Hudemann B; Seyfarth M
    Arch Geschwulstforsch; 1980; 50(2):173-7. PubMed ID: 7436702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Technics for the experimental study of delayed hypersensitivity].
    Lamarche M
    Ann Anesthesiol Fr; 1976; 17(3):371-7. PubMed ID: 10786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial bladder biopsy--important evolution prognosis factor of superficial bladder cancer under intravesical Bacille Calmette-Guérin therapy.
    Geavlete P; Taşcă C
    Rom J Morphol Embryol; 1991; 37(1-2):61-8. PubMed ID: 1801981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guérin (BCG): mechanism of action in superficial bladder cancer.
    Ratliff TL
    Urology; 1991; 37(5 Suppl):8-11. PubMed ID: 2021034
    [No Abstract]   [Full Text] [Related]  

  • 7. Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies.
    Ray MC; Tharp MD; Sullivan TJ; Tigelaar RE
    J Immunol; 1983 Sep; 131(3):1096-102. PubMed ID: 6193174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some newer approaches to the treatment of the mucosa of patients with superficial bladder cancer: 1. Continuous bladder irrigation with 5-fluorouracil.
    Connolly JG; Anderson C; Johnson I
    Can Med Assoc J; 1979 Aug; 121(3):318-20. PubMed ID: 466604
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group.
    Koontz WW; Heney NM; Soloway MS; Kluskens L; Hazra TA; Trump DL; Barton B
    Urology; 1985 Oct; 26(4 Suppl):30-1. PubMed ID: 3931326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravesical formalin on the destruction and regeneration of the canine bladder.
    Mulcahy JJ; Farrow GM; Furlow WL; Leary FJ
    Invest Urol; 1976 Nov; 14(3):177-81. PubMed ID: 992967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy of superficial bladder tumors in a hospital department].
    Prekopp G; Rosdy E
    Orv Hetil; 1993 Dec; 134(50):2757-60. PubMed ID: 8265124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental investigations of the optimal therapy of systemic BCG infection in vivo].
    Jurczok A; Zacharias M; Böhle A; Fornara P; Jocham D
    Aktuelle Urol; 2004 Sep; 35(5):406-12. PubMed ID: 15368130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxidative activity of blood serum ceruloplasmin in patients with pulmonary tuberculosis and eye diseases exhibiting delayed reactivity to dinitrofluorobenzene].
    Drozdowska S; Lipnicki B
    Klin Oczna; 1975 Jul; 45(7):807-9. PubMed ID: 1160302
    [No Abstract]   [Full Text] [Related]  

  • 14. [An evaluation of damage caused by radiation and chemical drugs to urinary bladder mucosa in stage T1-T2N0V0 cancer].
    Kaprin AD; Pan'shin GA; Garmash SV; Kostin AA; Khmelevskiĭ EV; Elagin VO
    Vopr Onkol; 2007; 53(4):473-6. PubMed ID: 17969414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental studies on intravesical instillation of 4'-epi-adriamycin for the treatment of bladder cancer].
    Tsushima T
    Hinyokika Kiyo; 1985 Nov; 31(11):1945-56. PubMed ID: 3867286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of BCG immunotherapy in the management of bladder tumors].
    Samodai L; Kiss L; Kolozsy Z; Dauda G; Drinóczy M; Mohácsi L
    Orv Hetil; 1990 Aug; 131(31):1697-702. PubMed ID: 2205825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
    Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
    Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on different responses of rats' small intestine mucous membrane and bladder transitional epithelium in the same carcinogenic urine environment].
    Wu B; Pan C; Song G
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1227-9. PubMed ID: 11825523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bladder tumors. Indications and results of systematic biopsies of optically normal mucosa (with a study of surface antigens)].
    Boccon-Gibod L; Boccon-Gibod L; Deslignères S; Janin-Mercier A
    Arch Anat Cytol Pathol; 1986; 34(4):224-9. PubMed ID: 3566364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.